Frederick R. Appelbaum
Appelbaum, Frederick R.
Appelbaum, Frederick R., 19..-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Appelbaum, F. R.
VIAF ID: 76562504 (Personal)
Permalink: http://viaf.org/viaf/76562504
Preferred Forms
-
200 _ |
‡a
Appelbaum
‡b
Frederick R.
-
100 1 _
‡a
Appelbaum, F. R.
-
100 1 _ ‡a Appelbaum, Frederick R. (sparse)
-
100 1 _ ‡a Appelbaum, Frederick R.
-
100 1 _ ‡a Appelbaum, Frederick R.
-
100 1 _
‡a
Appelbaum, Frederick R.
-
100 1 _ ‡a Appelbaum, Frederick R.
-
100 1 _ ‡a Appelbaum, Frederick R.
-
100 1 _ ‡a Appelbaum, Frederick R.
-
100 1 _
‡a
Appelbaum, Frederick R.,
‡d
19..-....
-
100 0 _
‡a
Frederick R. Appelbaum
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007 |
|
| Bone marrow transplantation [VR] c1989: |
|
| Hematopoietic cell transplantation |
|
| Leukemia and related disorders : integrated treatment approaches |
|
| Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts |
|
| The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults |
|
| Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML. |
|
| Targeted therapy for hematologic malignancies: has its promise been realized? |
|
| Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia |
|
| Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone |
|
| Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. |
|
| Therapy with mycophenolate mofetil for refractory acute and chronic GVHD. |
|
| Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets |
|
| To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision |
|
| Toxicity trial of prophylactic 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine (ganciclovir) after marrow transplantation in dogs |
|
| Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts |
|
| Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease |
|
| Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia |
|
| Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens |
|
| Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129 |
|
| Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone |
|
| Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. |
|
| Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells |
|
| Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody |
|
| Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience |
|
| Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study |
|
| Trisomy 11: an association with stem/progenitor cell immunophenotype |
|
| Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies |
|
| Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs |
|
| Unfavorable, complex, and monosomal karyotypes: the most challenging forms of acute myeloid leukemia. |
|
| Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors |
|
| Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia |
|
| US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL |
|
| Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation |
|
| Use of in vitro assays in selection of compatible platelet donors |
|
| The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia |
|
| Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies |
|
| Using a Transplant Recipient as a Donor: The Resilience of Multipotent Stem Cells in Humans |
|
| Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia |
|
| What pediatrics can teach us. |
|
| What radiation dose for DLA-identical canine marrow grafts? |
|
| What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? |
|
| Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? |
|
| Who should be transplanted for AML? |
|
| Wintrobe's clinical hematology. |
|
